Meanwhile, the same result showed that the expression of IL4I1, PROCA1, UBE2L6 and PSME1 expression were notably elevated in responder tissues compared to non‐responder tissues in NSCLC, RCC and STAD, respectively (Figure 6A–F). This evidence concerns the gene IL4I1 and non-small cell lung carcinoma.